Scotiabank analyst Nicholas Yulico raised the firm’s price target on Omega Healthcare (OHI) to $48 from $45 and keeps a Sector Perform rating on the shares. The firm is updating its price targets for U.S. Real Estate & REIT stocks under its coverage following Q4 results, the analyst tells investors. Scotiabank believes REITs should be raising target development yields to focus on near-term funds from operations per share impact and believes external growth from acquisitions offer a “better thematic story,” the firm adds.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare price target raised to $47 from $44 at RBC Capital
- Omega Healthcare price target raised to $52 from $50 at Cantor Fitzgerald
- Omega Healthcare Investors: Rising Operational and Earnings Risk as RIDEA Expansion Increases Dependence on Third-Party Managers
- Omega Healthcare Investors Signals Confident 2026 Earnings Path
- Omega Healthcare price target raised to $52 from $51 at UBS